CryoSpray Ablation(tm)Thoracic Patient Registry

CSA Medical

Status: Withdrawn

Conditions: Sarcoidosis; Asthma; Chronic Bronchitis; Emphysema; Lung Cancer; Mesothelioma; COPD

Study type: Observational

Funder types: Industry

Identifiers

NCT00785239

17-00031

Details and patient eligibility

About

The purpose of this study is to create a patient registry to collect and analyze information on subjects treated with the CryoSpray Ablation™ System post-510K approval.

Full description

The proposed registry is a prospective, multi-center study of patients that are currently undergoing CryoSpray Ablation™. A maximum of 50 investigational sites will participate in this study.

The study population consists of patients who are being treated with the CryoSpray Ablation™ System for thoracic diseases. Enrolled subjects must have a signed consent form for data collection.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients who are being treated with the CryoSpray Ablation™ System for lung and for thoracic diseases.

Exclusion criteria

• Subjects with thoracic or airway obstructions and diseases who were not treated with the CryoSpray Ablation™ System.
• Subjects under the age of 18 years.
• Subjects unable to provide consent.